Navigation Links
Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
Date:4/16/2012

By Kathleen Doheny
HealthDay Reporter

MONDAY, April 16 (HealthDay News) -- A bariatric surgical procedure is more likely than medicine to improve or even reverse type 2 diabetes in very obese patients, a new small study indicates.

Italian researchers compared standard diabetes medicine with a surgical procedure known as the laparoscopic sleeve gastrectomy, and while 80 percent of those treated with the surgery had remission of their diabetes within 18 months, none of those treated with medicine did.

"In our opinion, 80 percent diabetes resolution is a dramatically excellent result, compared with results of a medical approach in which there's not diabetes resolution," said lead researcher Dr. Nicola Basso, a professor of surgery at the University of Rome, Sapienza.

All of those who had surgery and had diabetes less than 10 years reversed it, Basso said.

The study appeared online April 16 in the Archives of Surgery.

In the procedure, doctors remove about 85 percent of the stomach and shape the remaining portion into a tube or sleeve. Fewer calories can be eaten, and weight loss is the result.

"At present, we think that sleeve gastrectomy may be considered the surgical procedure of choice in treating 'diabesity,'" said Basso.

The researchers assigned 30 patients to the surgery group and another 30 to the medicine group. All had a body-mass index (BMI) of 35 or higher. With BMI, which takes both height and weight into account, 30 is the beginning of the obese category.

A person who is 5-foot-10 and weighs 250 pounds has a BMI of nearly 36.

Basso's team followed the patients for 18 months to see what effect the treatments had on their diabetes and other health measures.

The surgery group's average BMI went from 41 to about 28. The medicine group's BMI, 39 on average at the start, went up slightly.

Those who had the surgery had improvements in other areas. Sleep apnea dropped from 50 percent to 10 percent. After surgery, patients reduced their use of medicine for high blood pressure and cholesterol problems.

None in the medicine group reversed their diabetes. Their need for high blood pressure medicine and cholesterol medicines increased, although not significantly. Their sleep apnea did not change.

The study results are not surprising, said Dr. Ronald Goldberg, a professor of medicine at the Diabetes Research Institute at the University of Miami Miller School of Medicine.

"It's fairly in line with previous research using different bypass procedures," he said.

The latest findings could be very good news for very obese patients with diabetes, he said.

"The milder type is much more likely to go into remission than someone who has longstanding or complicated diabetes," he said. The procedure is worth consideration by someone who is very obese and has type 2 diabetes, he added.

The cost of the procedure in the United States is between $10,000 and $15,000.

"There is no question that over the short term, surgery has to be more expensive," Goldberg said. "But with time, the increased cost of managing diabetes, and particularly its complications, would make a cost-benefit comparison more meaningful."

More information

To learn more about diabetes, visit the American Diabetes Association.

SOURCES: Nicola Basso, M.D., Ph.D., professor, surgery, University of Rome, Sapienza; Ronald Goldberg, M.D, endocrinologist and professor, medicine, University of Miami Miller School of Medicine; April 16, 2012, Archives of Surgery, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Weight-Loss Surgeries May Beat Standard Treatments for Diabetes
2. Weight-Loss Surgery Seems Safe for Kidney Disease Patients
3. Mid-morning snacking may sabotage weight-loss efforts
4. Weighing Weight-Loss Programs
5. Weight Watchers Produces Bigger Losers Than Standard Weight-Loss Care
6. U.S. Women Using Dangerous Weight-Loss Pill 2 Years After Recall
7. Weight-Loss Surgery Gains More Practitioners
8. Rigorous Exercise May Boost Benefits of Weight-Loss Surgery
9. Weight-loss surgery cost-effective for all obese
10. Weight-Loss Surgery Helps Less Obese Patients: Study
11. Can Weight-Loss Surgery Reverse Common Cause of Infertility?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology: